Recce Pharmaceuticals Ltd. (AU:RCE) has released an update. Recce Pharmaceuticals Ltd has secured a significant AUD $6.75 million R&D Tax Incentive rebate from the Australian Taxation Office ...
Recce Pharmaceuticals (Recce) has obtained approval from the Human Research Ethics Committee in Indonesia to initiate a registrational Phase III trial of its RECCE 327 (R327G) as a topical gel ...
Image: England seam bowler Reece Topley injured himself in the first T20 against West Indies in Barbados England seam bowler Reece Topley has been ruled out of the remainder of the T20 series ...
Its patented lead candidate, RECCE® 327 has been developed for the treatment of blood infections and sepsis derived from E. coli and S. aureus bacteria ÂÂÂÂÂÂÂÂÂÂÂÂÂÂ? including ...
R327G is a topical gel treatment being analysed for diabetic foot infections. Credit: Olga Apanasenko/Shutterstock. Recce Pharmaceuticals (Recce) has obtained approval from the Human Research Ethics ...
Stockhead’s ‘Garimpeiro’ columnist Barry FitzGerald is back in the studio for another instalment of The Explorers Podcast. In this episode Barry chats with Cullum Winn, CEO at Western Gold Resources ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback